Soluble TNFR1 Levels in Type 2 Diabetes and its Association with Stages of Proteinuria

Aims: Early identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels of circulating soluble tumor necrosis factor receptor 1 (sTNFR1) in various stages of proteinuria (MAC) to determine the association of this...

Full description

Saved in:
Bibliographic Details
Published inJournal of the Association of Physicians of India Vol. 71; no. 6; pp. 26 - 29
Main Authors Lourdusamy, Raghul, Gokulakrishnan, Kuppan, Nilavan, Ezhil, Balaji, Nandagopal, Srinivasan, Ramprasad
Format Journal Article
LanguageEnglish
Published India 01.06.2023
Subjects
Online AccessGet full text
ISSN0004-5772
DOI10.5005/japi-11001-0261

Cover

Abstract Aims: Early identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels of circulating soluble tumor necrosis factor receptor 1 (sTNFR1) in various stages of proteinuria (MAC) to determine the association of this marker with diabetic nephropathy. Materials and methods: The study was performed on 160 subjects, and a case-control methodology was employed. Type 2 diabetic subjects were recruited based on albuminuria and were grouped as (1) normoalbuminuria (NA); (2) microalbuminuria (MIC); (3) MAC; (4) normal glucose tolerance (NGT) subjects who served as healthy controls. sTNFR1 levels were measured by quantitative enzyme-linked immunosorbent assay (ELISA). Results: Soluble tumor necrosis factor receptor 1 (sTNFR1) levels were highest in the MAC group, followed by the microMAC group. The sTNFR1 levels were not statistically different between the NGT and NA groups. On regression models, sTNFR1 was associated with MIC [odds ratio (OR)— 6.491, 95% confidence interval (CI)—1.868–22.55] and MAC (OR per standard deviation—15.28; 95% CI—3.76–62.15; p < 0.001) even after controlling for all the possible confounding factors. Receiver operator curve (ROC) analysis revealed sTNFR1 cut-point of 1832 pg/mL had a C-statistic of 0.685 to discriminate MI from NA with 52% sensitivity. Whereas the sTNFR1 cut-point of 2050 pg/mL with a C-statistic of 0.8177 had 77% sensitivity for identifying MAC. Conclusion: Soluble tumor necrosis factor receptor 1 (sTNFR1) is significantly associated with MIC and MAC group in type 2 diabetes, and this suggests a potential early diagnostic biomarker role of sTNFR1 for MAC among Asian Indians.
AbstractList Early identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels of circulating soluble tumor necrosis factor receptor 1 (sTNFR1) in various stages of proteinuria (MAC) to determine the association of this marker with diabetic nephropathy. The study was performed on 160 subjects, and a case-control methodology was employed. Type 2 diabetic subjects were recruited based on albuminuria and were grouped as (1) normoalbuminuria (NA); (2) microalbuminuria (MIC); (3) MAC; (4) normal glucose tolerance (NGT) subjects who served as healthy controls. sTNFR1 levels were measured by quantitative enzyme-linked immunosorbent assay (ELISA). Soluble tumor necrosis factor receptor 1 (sTNFR1) levels were highest in the MAC group, followed by the microMAC group. The sTNFR1 levels were not statistically different between the NGT and NA groups. On regression models, sTNFR1 was associated with MIC [odds ratio (OR)- 6.491, 95% confidence interval (CI)-1.868-22.55] and MAC (OR per standard deviation-15.28; 95% CI-3.76-62.15; p < 0.001) even after controlling for all the possible confounding factors. Receiver operator curve (ROC) analysis revealed sTNFR1 cut-point of 1832 pg/mL had a C-statistic of 0.685 to discriminate MI from NA with 52% sensitivity. Whereas the sTNFR1 cut-point of 2050 pg/mL with a C-statistic of 0.8177 had 77% sensitivity for identifying MAC. Soluble tumor necrosis factor receptor 1 (sTNFR1) is significantly associated with MIC and MAC group in type 2 diabetes, and this suggests a potential early diagnostic biomarker role of sTNFR1 for MAC among Asian Indians.
Early identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels of circulating soluble tumor necrosis factor receptor 1 (sTNFR1) in various stages of proteinuria (MAC) to determine the association of this marker with diabetic nephropathy.AIMSEarly identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels of circulating soluble tumor necrosis factor receptor 1 (sTNFR1) in various stages of proteinuria (MAC) to determine the association of this marker with diabetic nephropathy.The study was performed on 160 subjects, and a case-control methodology was employed. Type 2 diabetic subjects were recruited based on albuminuria and were grouped as (1) normoalbuminuria (NA); (2) microalbuminuria (MIC); (3) MAC; (4) normal glucose tolerance (NGT) subjects who served as healthy controls. sTNFR1 levels were measured by quantitative enzyme-linked immunosorbent assay (ELISA).MATERIALS AND METHODSThe study was performed on 160 subjects, and a case-control methodology was employed. Type 2 diabetic subjects were recruited based on albuminuria and were grouped as (1) normoalbuminuria (NA); (2) microalbuminuria (MIC); (3) MAC; (4) normal glucose tolerance (NGT) subjects who served as healthy controls. sTNFR1 levels were measured by quantitative enzyme-linked immunosorbent assay (ELISA).Soluble tumor necrosis factor receptor 1 (sTNFR1) levels were highest in the MAC group, followed by the microMAC group. The sTNFR1 levels were not statistically different between the NGT and NA groups. On regression models, sTNFR1 was associated with MIC [odds ratio (OR)- 6.491, 95% confidence interval (CI)-1.868-22.55] and MAC (OR per standard deviation-15.28; 95% CI-3.76-62.15; p < 0.001) even after controlling for all the possible confounding factors. Receiver operator curve (ROC) analysis revealed sTNFR1 cut-point of 1832 pg/mL had a C-statistic of 0.685 to discriminate MI from NA with 52% sensitivity. Whereas the sTNFR1 cut-point of 2050 pg/mL with a C-statistic of 0.8177 had 77% sensitivity for identifying MAC.RESULTSSoluble tumor necrosis factor receptor 1 (sTNFR1) levels were highest in the MAC group, followed by the microMAC group. The sTNFR1 levels were not statistically different between the NGT and NA groups. On regression models, sTNFR1 was associated with MIC [odds ratio (OR)- 6.491, 95% confidence interval (CI)-1.868-22.55] and MAC (OR per standard deviation-15.28; 95% CI-3.76-62.15; p < 0.001) even after controlling for all the possible confounding factors. Receiver operator curve (ROC) analysis revealed sTNFR1 cut-point of 1832 pg/mL had a C-statistic of 0.685 to discriminate MI from NA with 52% sensitivity. Whereas the sTNFR1 cut-point of 2050 pg/mL with a C-statistic of 0.8177 had 77% sensitivity for identifying MAC.Soluble tumor necrosis factor receptor 1 (sTNFR1) is significantly associated with MIC and MAC group in type 2 diabetes, and this suggests a potential early diagnostic biomarker role of sTNFR1 for MAC among Asian Indians.CONCLUSIONSoluble tumor necrosis factor receptor 1 (sTNFR1) is significantly associated with MIC and MAC group in type 2 diabetes, and this suggests a potential early diagnostic biomarker role of sTNFR1 for MAC among Asian Indians.
Aims: Early identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels of circulating soluble tumor necrosis factor receptor 1 (sTNFR1) in various stages of proteinuria (MAC) to determine the association of this marker with diabetic nephropathy. Materials and methods: The study was performed on 160 subjects, and a case-control methodology was employed. Type 2 diabetic subjects were recruited based on albuminuria and were grouped as (1) normoalbuminuria (NA); (2) microalbuminuria (MIC); (3) MAC; (4) normal glucose tolerance (NGT) subjects who served as healthy controls. sTNFR1 levels were measured by quantitative enzyme-linked immunosorbent assay (ELISA). Results: Soluble tumor necrosis factor receptor 1 (sTNFR1) levels were highest in the MAC group, followed by the microMAC group. The sTNFR1 levels were not statistically different between the NGT and NA groups. On regression models, sTNFR1 was associated with MIC [odds ratio (OR)— 6.491, 95% confidence interval (CI)—1.868–22.55] and MAC (OR per standard deviation—15.28; 95% CI—3.76–62.15; p < 0.001) even after controlling for all the possible confounding factors. Receiver operator curve (ROC) analysis revealed sTNFR1 cut-point of 1832 pg/mL had a C-statistic of 0.685 to discriminate MI from NA with 52% sensitivity. Whereas the sTNFR1 cut-point of 2050 pg/mL with a C-statistic of 0.8177 had 77% sensitivity for identifying MAC. Conclusion: Soluble tumor necrosis factor receptor 1 (sTNFR1) is significantly associated with MIC and MAC group in type 2 diabetes, and this suggests a potential early diagnostic biomarker role of sTNFR1 for MAC among Asian Indians.
Author Nilavan, Ezhil
Lourdusamy, Raghul
Gokulakrishnan, Kuppan
Balaji, Nandagopal
Srinivasan, Ramprasad
Author_xml – sequence: 1
  givenname: Raghul
  surname: Lourdusamy
  fullname: Lourdusamy, Raghul
– sequence: 2
  givenname: Kuppan
  surname: Gokulakrishnan
  fullname: Gokulakrishnan, Kuppan
– sequence: 3
  givenname: Ezhil
  surname: Nilavan
  fullname: Nilavan, Ezhil
– sequence: 4
  givenname: Nandagopal
  surname: Balaji
  fullname: Balaji, Nandagopal
– sequence: 5
  givenname: Ramprasad
  surname: Srinivasan
  fullname: Srinivasan, Ramprasad
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37355839$$D View this record in MEDLINE/PubMed
BookMark eNqFkDtPwzAUhT0U0QfMbMgjS-j1q4nHqlBAqgDRwho5yQ24SuMQJ1T996S0sDLd4XznXOkbkl7pSiTkgsG1AlDjtalswBgAC4BPWI8MAEAGKgx5nwy9XwMILQQ_JX0RCqUioQfkbemKNimQrh7nL4wu8AsLT21JV7sKKac31iTYoKemzKhtPJ1671JrGutKurXNB1025r3LXU6fa9egLdvamjNykpvC4_nxjsjr_HY1uw8WT3cPs-kiSDmELMA0UjxLmZYI0YSrnIVCcpQsNQKiZGKU1hGHRJsky_WEaZ6ISCaSZWHOZZiJEYHDbltWZrc1RRFXtd2YehcziPda4r2W-EdLvNfSVa4Olap2ny36Jt5Yn2JRmBJd62MecS0F5zrs0Msj2iYbzP6mf_V1wPgApLXzvsb83-_fp2Z9zA
ContentType Journal Article
Copyright Journal of the Association of Physicians of India 2011.
Copyright_xml – notice: Journal of the Association of Physicians of India 2011.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
DOI 10.5005/japi-11001-0261
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 29
ExternalDocumentID 10.5005/japi-11001-0261
37355839
10_5005_japi_11001_0261
Genre Journal Article
GroupedDBID ---
29L
2WC
53G
5GY
AAYXX
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CITATION
DIK
EBS
EJD
F5P
GX1
OK1
OVT
RNS
TR2
XSB
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
ID FETCH-LOGICAL-c2071-ec852dc194e08625f17342e41ca308b6a599820b9abdf96192b384b41d7f247d3
ISSN 0004-5772
IngestDate Tue Aug 19 22:14:37 EDT 2025
Thu Jul 10 19:30:09 EDT 2025
Wed Feb 19 02:24:02 EST 2025
Wed Oct 01 08:23:58 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License Journal of the Association of Physicians of India 2011.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2071-ec852dc194e08625f17342e41ca308b6a599820b9abdf96192b384b41d7f247d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.5005/japi-11001-0261
PMID 37355839
PQID 2829432297
PQPubID 23479
PageCount 4
ParticipantIDs unpaywall_primary_10_5005_japi_11001_0261
proquest_miscellaneous_2829432297
pubmed_primary_37355839
crossref_primary_10_5005_japi_11001_0261
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-06-01
PublicationDateYYYYMMDD 2023-06-01
PublicationDate_xml – month: 06
  year: 2023
  text: 2023-06-01
  day: 01
PublicationDecade 2020
PublicationPlace India
PublicationPlace_xml – name: India
PublicationTitle Journal of the Association of Physicians of India
PublicationTitleAlternate J Assoc Physicians India
PublicationYear 2023
SSID ssj0039332
Score 2.327677
Snippet Aims: Early identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels...
Early identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels of...
SourceID unpaywall
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 26
SubjectTerms Albuminuria - diagnosis
Diabetes Mellitus, Type 2 - complications
Diabetic Nephropathies - complications
Humans
Proteinuria - etiology
Receptors, Tumor Necrosis Factor, Type I
Title Soluble TNFR1 Levels in Type 2 Diabetes and its Association with Stages of Proteinuria
URI https://www.ncbi.nlm.nih.gov/pubmed/37355839
https://www.proquest.com/docview/2829432297
https://doi.org/10.5005/japi-11001-0261
UnpaywallVersion publishedVersion
Volume 71
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  issn: 0004-5772
  databaseCode: DIK
  dateStart: 20030101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: http://www.freemedicaljournals.com
  omitProxy: true
  ssIdentifier: ssj0039332
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  issn: 0004-5772
  databaseCode: GX1
  dateStart: 20030101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  omitProxy: true
  ssIdentifier: ssj0039332
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkGA8IO6Um4yEEAgZGtuJk0cu7SboCkIp6lvkXLxlK2mgjRDjz-MTO5eNSQxeoipS7Oo7n47POT4XhJ640suoEoKMqHIJz0RCpHAVianjCc8Vjgyg3nlv5u3O-fuFuxgMfvWrSzbxy-T4zLqS_5GqfqflClWy_yDZdlH9Qv_W8tVPLWH9PJeMIaYFlU_hbPLZeTGF_J86vTU0cdV3TVy1uSDoycIEYLWpuW-6zn6Cfg15UZms47Ps1boGpbcAfNSERdamIiXNWyU_1R-m1Vp-NUKU-wddBuLO6qhayiOYbW-nI3-oyrKj6SxfSns_NT4-6HJA3silPMztmZDCABcLkI1aUNZlV7WamBNXiBOaWDg9xvXVqtHHp7W9qzVIPWWgzAl0vnMIOJTdwdZc5s8-RpP5dBqF40X4tPxGYOQYXM3b-SsX0EUqPA_GX-ws2vwgFjBmWs3bP2r6QsGer07teNKk-cNPuYIuV0Upf_6Qy2XPdgmvoatWiPi1YdB1NMiKG-jSnk2ruIm-WCLhmkjYEAnnBQYiYYobImENO9ZEwj0eYCASNkTCK4V7RLqF5pNx-HaX2IEbJKHa1CRZ4rs0TZyAZ-DpusoRjNOMO4lkIz_2pKudczqKAxmnKgDXO2Y-j7mTCkW5SNlttFWsiuwuwirx_ECwTAXS5wmXQezFwkt5oqA9kM-H6FmDWVSaviqR9kcB3gjgjWp4I4B3iB43mEZa98GFliyyVbWOIAuA6xMpEEN0x4DdLsYEDA5gwRA9b9H_2073zrHTfbTd8fkB2tp8r7KH2i7dxI9q_vwGYImPNw
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Soluble+TNFR1+Levels+in+Type+2+Diabetes+and+its+Association+with+Stages+of+Proteinuria&rft.jtitle=Journal+of+the+Association+of+Physicians+of+India&rft.au=Lourdusamy%2C+Raghul&rft.au=Gokulakrishnan%2C+Kuppan&rft.au=Nilavan%2C+Ezhil&rft.au=Balaji%2C+Nandagopal&rft.date=2023-06-01&rft.issn=0004-5772&rft.volume=71&rft.issue=6&rft.spage=11&rft_id=info:doi/10.5005%2Fjapi-11001-0261&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-5772&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-5772&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-5772&client=summon